Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations.

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1069-1077
    JournalPharmacoeconomics
    Volume19
    Issue number11
    Publication statusPublished - 1 Jan 2001

    Keywords

    • PHARMACOLOGY & PHARMACY

    Cite this